Mechanisms of Early Kidney Development
早期肾脏发育的机制
基本信息
- 批准号:7253871
- 负责人:
- 金额:$ 24.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AngioblastAntibodiesAortaAppearanceArteriesBirdsBlood VesselsCardinal veinCell TherapyChemicalsChimera organismCoculture TechniquesCollagenDevelopmentDiseaseDisruptionEmbryoEmbryonic HeartEmbryonic arterial structureEndothelial CellsEphrin-B2Figs - dietaryGelGeneticHensen&aposs NodeIntermediate MesodermKidneyLaboratoriesLinkLiverMapsMedialMesodermModelingMolecularMusMutant Strains MicePancreasParaxial MesodermPatternPilot ProjectsPrimitive StreaksPronephric DuctPronephric structureQuailRenal functionResolutionRoleSignal TransductionSomitesStagingTimeTissue EngineeringTissuesTransplantationVascular Endothelial Growth Factor Receptor-2Vascular Endothelial Growth FactorsVeinsVenousVideo MicroscopyZebrafishbasedaynephrogenesisresearch studysomitogenesisstem cell technologytime usevasculogenesis
项目摘要
DESCRIPTION (provided by applicant): Recent advances in stem cell technology offer hope that cell therapy and tissue engineering may one day replace renal function lost as a consequence of maldevelopment or disease. Prerequisite to tissue engineering is the understanding of the mechanisms underlying embryonic kidney induction and development. The pronephros arises directly from intermediate mesoderm (IM) and represents the first stage of vertebrate kidney induction. Paraxial mesoderm (PM), which gives rise to somites, induces the pronephros, but the cellular and molecular mechanisms underlying pronephros induction by the PM have not been defined. Somitogenesis and pronephros induction are closely linked to vascular development. The pronephros lies sandwiched between the post-cardinal vein and the aorta in the early embryo, and the PM contains angioblasts. Angioblast-derived signals induce the embryonic heart, pancreas, and liver, suggesting that this may be a general inductive mechanism. Pilot studies showed that inhibition of vasculogenesis decreased expression of the kidney marker, pax-2, in the IM, and suggested that the timing of vascular disruption is important. We hypothesize that molecules secreted by resident angioblasts regulate pronephros induction by the paraxial mesoderm. We know that angioblasts meet the temporal and spatial criteria for a pronephros inducer. In Aim 1, we will define the temporal and spatial appearance of blood vessel precursors in relation to pronephros induction using high-resolution fate mapping. Time-lapse videomicroscopy will follow the development of PM, IM angioblasts, and blood vessels. We will determine whether ectopically induced somites and pronephroi form in association with ectopic blood vessels. Results of these studies will help us understand the details of interactions between angioblasts, PM and IM during their specification. Aim 2 will determine if blood vessel precursors are required for pronephros induction by PM, thereby fulfilling the second criterion for an inducer. We will determine if PM obtained from VEGFR2 (-/-) mice, which lack blood vessels, can induce the pronephros in competent (able to form pronephros) quail mesoderm. Soluble VEGF-R1 will be injected into quail mesoderm to disrupt vasculogenesis, and secondarily, pronephros induction. Aim 3 will determine if blood vessels are sufficient for pronephros induction and thus fulfill the third criterion for an inducer. We will examine the effect of ectopic or excessive blood vessel formation on pronephros induction, and we will recombine embryonic arteries and veins with uninduced competent mesoderm in collagen gel cultures to determine if pronephros induction is specific to a particular vascular type, or is a general feature of blood vessels and angioblasts. The experiments described in this proposal will combine the ease of experimental manipulation of the avian model with the genetic power of mutant mice to define the molecular relationships between blood vessel formation, somitogenesis and pronephros induction.
描述(由申请人提供):干细胞技术的最新进展带来了希望,即细胞疗法和组织工程有一天可以取代因发育不良或疾病而丧失的肾功能。组织工程的先决条件是了解胚胎肾诱导和发育的机制。前肾直接起源于中间中胚层 (IM),代表脊椎动物肾脏诱导的第一阶段。近轴中胚层 (PM) 产生体节,诱导前肾,但 PM 诱导前肾的细胞和分子机制尚未明确。体细胞发生和前肾诱导与血管发育密切相关。在早期胚胎中,前肾位于后主静脉和主动脉之间,前肾含有成血管细胞。成血管细胞衍生的信号诱导胚胎心脏、胰腺和肝脏,表明这可能是一种普遍的诱导机制。初步研究表明,抑制血管生成会降低 IM 中肾脏标志物 pax-2 的表达,并表明血管破坏的时机很重要。我们假设常驻成血管细胞分泌的分子通过轴旁中胚层调节前肾诱导。我们知道成血管细胞符合前肾诱导剂的时间和空间标准。在目标 1 中,我们将使用高分辨率命运图来定义与前肾诱导相关的血管前体的时间和空间外观。延时视频显微镜将跟踪 PM、IM 成血管细胞和血管的发育。我们将确定异位诱导的体节和原肾的形成是否与异位血管有关。这些研究的结果将帮助我们了解成血管细胞、PM 和 IM 在其规范过程中相互作用的细节。目标 2 将确定 PM 诱导前肾是否需要血管前体,从而满足诱导剂的第二个标准。我们将确定从缺乏血管的 VEGFR2 (-/-) 小鼠获得的 PM 是否可以诱导有能力(能够形成前肾)的鹌鹑中胚层中的前肾。可溶性 VEGF-R1 将被注射到鹌鹑中胚层中,以破坏血管生成,其次是前肾诱导。目标 3 将确定血管是否足以进行前肾诱导,从而满足诱导剂的第三个标准。我们将检查异位或过度血管形成对前肾诱导的影响,并且我们将在胶原凝胶培养物中将胚胎动脉和静脉与未诱导的有能力的中胚层重组,以确定前肾诱导是否特定于特定血管类型,或者是血管和成血管细胞的一般特征。该提案中描述的实验将把禽类模型的实验操作简便性与突变小鼠的遗传能力结合起来,以确定血管形成、体细胞发生和前肾诱导之间的分子关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TERI J MAUCH其他文献
TERI J MAUCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TERI J MAUCH', 18)}}的其他基金
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 24.24万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 24.24万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 24.24万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 24.24万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 24.24万 - 项目类别: